Understanding the structure and function of HIV RNA
Center for Structural Biology of HIV RNA
['FUNDING_OTHER'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-11059970
This study is looking at the genetic material of HIV to find new ways to treat the virus, using cutting-edge technology to understand how HIV works and how it interacts with proteins, with the hope of creating new treatments that target the virus more effectively.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-11059970 on ClinicalTrials.gov |
What this research studies
This research focuses on exploring the biology and chemistry of HIV RNA to identify new targets for treatment. It employs advanced techniques such as next-generation sequencing and CRISPR screening to discover new features of HIV-1 RNAs and their interactions with proteins. The goal is to develop RNA-targeted inhibitors that could disrupt the biological processes of the virus. By combining molecular biology with cheminformatics and machine learning, the research aims to enhance our understanding of HIV and improve therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are seeking new treatment options.
Not a fit: Patients who are not infected with HIV or those who are not interested in experimental treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments for HIV, potentially improving the lives of those living with the virus.
How similar studies have performed: Previous research has shown promise in targeting RNA structures in viruses, indicating that this approach could lead to significant advancements in HIV treatment.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TELESNITSKY, ALICE — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: TELESNITSKY, ALICE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus